A study has revealed that in rhesus monkeys, a genetic mutation could
be the cause of Bardet-Biedl Syndrome, providing a way to study the disease and
develop therapies.
Researchers have discovered a genetic mutation in rhesus monkeys that
leads to the rare Bardet-Biedl Syndrome (BBS). According to the team, their
findings offer a promising way to develop gene and cell therapies to treat the
condition in human patients.
The research was conducted at the Oregon Health & Science
University (OHSU), US and offers the first known naturally occurring nonhuman
primate model of the syndrome which causes vision loss, kidney dysfunction and
extra fingers or toes.
Two related monkeys without cells critical for vision were discovered
by the researchers. Examining their genomes, they found that both monkeys had a
mutation in the BBS7 gene, one of at least 14 genes associated with BBS.
The team then searched a genome database of the monkeys at the Oregon
National Primate Research Center at OHSU. They identified a third monkey that
had the same mutation and has severe BBS symptoms.
The group are now breeding more animals with the naturally occurring
BBS7 mutation, as having more animals with the mutation can enable them to
develop cell and gene therapies.
“There is no cure for BBS today but having a naturally occurring animal
model for the condition could help us find one in the future,†said the paper’s
corresponding author, Dr Martha Neuringer, a professor of neuroscience at the
Oregon National Primate Research Center at OHSU.
The researchers say that their discovery could also be used to develop treatments for other retinitis pigmentosa diseases.
.png)
.jpg)
.gif)
